IRIS Accounts Production v23.3.1.45 10964360 director 1.10.22 30.9.23 30.9.23 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh109643602022-09-30109643602023-09-30109643602022-10-012023-09-30109643602021-09-30109643602021-10-012022-09-30109643602022-09-3010964360ns10:Originalns15:EnglandWales2022-10-012023-09-3010964360ns14:PoundSterlingns10:Original2022-10-012023-09-3010964360ns10:Originalns10:Director12022-10-012023-09-3010964360ns10:Original2022-10-012023-09-3010964360ns10:Original2023-09-3010964360ns10:Originalns10:PrivateLimitedCompanyLtd2022-10-012023-09-3010964360ns10:Originalns10:Micro-entities2022-10-012023-09-3010964360ns10:Originalns10:AuditExempt-NoAccountantsReport2022-10-012023-09-3010964360ns10:Originalns10:FullAccounts2022-10-012023-09-3010964360ns10:CompanySecretary1ns10:Original2022-10-012023-09-3010964360ns10:Originalns10:RegisteredOffice2022-10-012023-09-3010964360ns10:Original2022-09-3010964360ns10:Originalns5:CurrentFinancialInstruments2023-09-3010964360ns10:Originalns5:CurrentFinancialInstruments2022-09-3010964360ns10:Original2021-10-012022-09-3010964360ns10:Original1ns10:Director12022-09-3010964360ns10:Original1ns10:Director12021-09-3010964360ns10:Original1ns10:Director12022-10-012023-09-3010964360ns10:Original1ns10:Director12021-10-012022-09-3010964360ns10:Original1ns10:Director12023-09-3010964360ns10:Original1ns10:Director12022-09-30
REGISTERED NUMBER: 10964360 (England and Wales)








Unaudited Financial Statements

for the Year Ended

30 September 2023

for

Midland Nose Surgery Limited

Midland Nose Surgery Limited (by shares) (Registered number: 10964360)






Contents of the Financial Statements
for the Year Ended 30 September 2023




Page

Company Information 1

Balance Sheet 2


Midland Nose Surgery Limited (by shares)

Company Information
for the Year Ended 30 September 2023







DIRECTOR: Dr J P Barraclough





SECRETARY: D Barraclough





REGISTERED OFFICE: Church Court
Stourbridge Road
Halesowen
West Midlands
B63 3TT





REGISTERED NUMBER: 10964360 (England and Wales)





ACCOUNTANTS: HSP Nicklin Limited
Church Court
Stourbridge Road
Halesowen
West Midlands
B63 3TT

Midland Nose Surgery Limited (by shares) (Registered number: 10964360)

Balance Sheet
30 September 2023

2023 2022
£    £    £    £   
FIXED ASSETS - 608

CURRENT ASSETS 37,853 135,104

CREDITORS
Amounts falling due within one year (14,720 ) (14,562 )
NET CURRENT ASSETS 23,133 120,542
TOTAL ASSETS LESS CURRENT
LIABILITIES

23,133

121,150

CAPITAL AND RESERVES 23,133 121,150

NOTES TO THE FINANCIAL STATEMENTS

1. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 2 (2022 - 2 ) .

2. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 30 September 2023 and 30 September 2022:

2023 2022
£    £   
Dr J P Barraclough
Balance outstanding at start of year - -
Amounts advanced 12,755 -
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 12,755 -



The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Midland Nose Surgery Limited (by shares) (Registered number: 10964360)

Balance Sheet - continued
30 September 2023


The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 19 January 2024 and were signed by:





Dr J P Barraclough - Director